Abstract:TCDD-inducible poly(ADP-ribose) polymerase (TIPARP, best known as PARP7) has previously been shown to promote oncogenesis by limiting the cytosolic accumulation of potentially interferogenic nucleic acids in malignant cells or the precursors thereof. Recent data indicate that the oncogenic activity of PARP7 is derived at least partially from its ability to suppress apoptotic cell death upon mono-ADP-ribosylation of FOS-like 1, AP-1 transcription factor subunit (FOSL1, best known as FRA1) [1]. The natural and therapy-driven control of malignant lesions by the host immune system ( i.e ., immunosurveillance) ultimately relies on the activation of adaptive, tumor-specific immunity, with a prominent role for type I interferon (IFN) signaling originating from neoplastic (and non-neoplastic) components of the tumor microenvironment [2, 3]. PARP7 is a poorly investigated member of the poly(ADP-ribose) polymerase (PARP) protein family that has been shown to suppress type I IFN signaling in malignant cells by ensuring proficient DNA repair and hence limiting the cytosolic accumulation of potentially interferogenic nucleic acids [4]. Similar to several other proteins involved in DNA repair, PARP family members play a major role in the maintenance of genomic integrity during exposure to stress, including oncogenic stress, de facto preventing the initiation of (generally) unwarranted inflammatory responses [5]. Recent data have demonstrated that in addition to suppressing type I IFN responses in malignant cells, PARP7 restricts the activation of cancer cell-intrinsic oncosuppressive programs orchestrated by interferon regulatory factor 1 (IRF1) and IRF3 that culminate in caspase 8 (CASP8) activation and apoptotic cell death [1].

Poly(ADP-ribosylation) of P-TEFb by PARP1 disrupts phase separation to inhibit global transcription after DNA damage

Human PARP1 Substrates and Regulators of Its Catalytic Activity: an Updated Overview.

PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repair.

PARP1 allows proper telomere replication through TRF1 poly (ADP-ribosyl)ation and helicase recruitment

PARP1-dependent DNA-protein crosslink repair

TiPARP Forms Nuclear Condensates to Degrade HIF-1α and Suppress Tumorigenesis

Functional Aspects of PARP1 in DNA Repair and Transcription

A PARylation-phosphorylation cascade promotes TOPBP1 loading and RPA-RAD51 exchange in homologous recombination

PARP1: Liaison of Chromatin Remodeling and Transcription

Poly(ADP-ribosyl)ation mediates early phase histone eviction at DNA lesions

PARP1 interacts with WDR5 to enhance target gene recognition and facilitate tumorigenesis

Poly(ADP-ribosyl)ation of FOXP3 Protein Mediated by PARP-1 Protein Regulates the Function of Regulatory T Cells.

Transcription–replication conflicts underlie sensitivity to PARP inhibitors

EZH2 directly methylates PARP1 and regulates its activity in cancer

The TIMELESS and PARP1 interaction suppresses replication-associated DNA gap accumulation

PARP7 and nucleic acid-driven oncosuppression

Disrupting the Cdk9/Cyclin T1 heterodimer of 7SK snRNP for the Brd4 and AFF1/4 guided reconstitution of active P-TEFb

PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription

Coordination of transcription-coupled repair and repair-independent release of lesion-stalled RNA polymerase II

PARP1 associates with R-loops to promote their resolution and genome stability

Coordination of transcription-coupled repair and repair-independent release of stalled RNA polymerase II in response to transcription-blocking lesions